Clinical Research, Pharma & Healthcare FinancingAstellas & Vir Biotech Team on PRO-XTEN® VIR-5500 Cancer DrugPR NewswireFebruary 24, 2026February 25, 2026 by PR NewswireFebruary 24, 2026February 25, 2026091 – Astellas and Vir Biotechnology to co-develop and co-commercialize VIR-5500 through a sharing of expenses and revenues – – Astellas to lead commercialization of VIR-5500 in...
